Navigation Links
Johns Hopkins School of Medicine postdoctoral fellows win awards
Date:2/9/2011

Nine Johns Hopkins University School of Medicine postdoctoral fellows recently were awarded fellowships. Rita Strack, Ph.D., received one of 12 total Damon Runyon Cancer Research Foundation fellowships, and Bagrat Abazyan, M.D., Robert H. Cudmore, Ph.D., Mi-Hyeon Jang, Ph.D., Shinichi Kano, Sun-Hong Kim, Ph.D., M.D., Ph.D., Minae Niwa, Ph.D., Frederick Charles Nucifora Jr., Ph.D., D.O., M.H.S., and Emily G. Severance, Ph.D., were among the 214 recipients of the NARSAD: The Brain and Behavior Research Fund Young Investigator fellowship.

The Damon Runyon Cancer Research Foundation, a nonprofit organization focused on supporting innovative early career researchers, encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($156,000 over three years) to work on innovative projects. Rita L. Strack, Ph.D., a postdoc in molecular biology and genetics, is studying how cells ensure quality control during protein synthesis. The quality control process, called nonsense-mediated decay, is essential for cells to function properly; synthesizing defective proteins can lead to many types of cancer. This process may be a novel target for cancer diagnosis or therapeutics.

Since 1987, NARSAD: The Brain and Behavior Research Fund has awarded more than $274 million in 4,046 grants to 3,319 scientists around the world. Receiving up to $60,000 over two years, the fellowship recipients pursue brain and behavior research related to schizophrenia, depression, bipolar disorder, autism, ADHD and anxiety disorders, such as OCD and PTSD.

Robert H. Cudmore, Ph.D., a postdoctoral fellow in neuroscience, is studying on the cellular level the effects of exercise as an alternative and complementary treatment for mood disorders. Minae Niwa, Ph.D., of of psychiatry and behavioral sciences, is studying how the immune system affects functioning of the dopamine neurotransmitter system to induce psychiatric disorders. Frederick Charles Nucifora Jr., Ph.D., D.O., M.H.S., an assistant professor of psychiatry, is exploring the role of a gene called neuronal PAS3 (NPAS3) in schizophrenia. Bagrat Abazyan, M.D., a fellow in psychiatry and behavioral sciences, is generating a mouse model of a gene that when functioning abnormally in brain cells may contribute to symptoms of schizophrenia. Mi-Hyeon Jang, Ph.D., a postdoctoral fellow in neurology, is exploring how new cells are born in the hippocampal region of the brain and how this is affected by the so-called disrupted-in-schizophrenia-1 (DISC1) gene. Shinichi Kano, M.D., Ph.D., of psychiatry and behavioral sciences, is investigating a mechanism through which altered glial cells and infection may work synergistically to contribute to schizophrenia. Sun-Hong Kim, Ph.D., a postdoctoral fellow in psychiatry and behavioral sciences, is studying a new mediator of nitric oxide-regulated behaviors in relation to brain development disturbances implicated in schizophrenia. Emily G. Severance, Ph.D., a research associate in pediatrics, is testing whether a breached gastrointestinal barrier contributes to symptoms of psychiatric disorders.


'/>"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Jimmy Johnson Will Step Into Role as Honorary Crew Chief for ExtenZe Racing at Daytona
2. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
3. Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services
4. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
5. AADR awards the 2010 Jack Hein Public Service Award to David C. Johnsen
6. Johnson & Johnson to Participate in RBC Capital Markets Health Care Conference
7. Robert Wood Johnson Foundation Launches New Scholars, Fellows & Leadership Programs Web Site
8. Johns Hopkins Launches “Energy Policy and Climate” Master's Degree
9. SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria
10. Johns Hopkins Health System Acquires Imorgon Ultrasound PACS Product
11. Cancer research award to Johns Hopkins basic scientist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... "The World Market for Companion Diagnostic Tests" report to ... World Market for Companion Diagnostics The World ... diagnostic and personalized medicine diagnostics. Market analysis in the report ... Diagnostics Test Market (In Vitro Diagnostic Kits) by Region (N. ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology: